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CD40 Is a Cellular Receptor Mediating
Mycobacterial Heat Shock Protein 70
Stimulation of CC-Chemokines
response. Antigenic peptides linked to HSP70 can elicit
both MHC class I-restricted CD8 and MHC class II-
restricted CD4 T cell responses (Udono and Srivastava,
1993; Suto and Srivastava, 1995; Suzue and Young,
1996; Ciupitu et al., 1998; Huang et al., 2000). HSP70
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both in vivo and in vitro antigen-primed and to a lesserGmbH, Braunschweig
extent naive PBMC to produce the CC-chemokinesGermany
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finding may explain the adjuvant function of Mtb HSP70Jonsson Comprehensive Cancer Center
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and presenting macrophages, dendritic cells (DC), and
effector T and B cells (Baggiolini, 1998). The innate func-
tion of Mtb HSP70 in stimulating CC-chemokines is me-Summary
diated by host receptors for Mtb HSP70, although the
identity of these receptors has not been determined.The 70 kDa mycobacterial heat shock protein (Mtb
In view of the adjuvanticity of Mtb HSP70, we haveHSP70) stimulates mononuclear cells to release CC-
considered the hypothesis that Mtb HSP70 might upreg-chemokines. We now show that this function of Mtb
ulate CC-chemokines via the costimulatory receptors.HSP70, but not human HSP70, is dependent on the
This was based on the report that CC-chemokines arecell surface expression of CD40. Deletion of the CD40
upregulated by ligation of the CD28 molecule with B7cytoplasmic tail abolished, and CD40 antibody inhib-
(Herold et al., 1997) or interaction of CD40 with CD40ited, Mtb HSP70 stimulation of CC-chemokine release.
ligand (Kornbluth et al., 1998; McDyer et al., 1999). CD40Mtb HSP70 stimulated THP1, KG1 cells, and mono-
is a 50 kDa member of the TNF receptor family andcyte-derived dendritic cells to produce RANTES. Spe-
is expressed on B cells, monocytes, mature DC, andcific binding of CD40-transfected HEK 293 cells to
nonhematopoietic cells (Banchereau et al., 1994; YoungMtb HSP70 was demonstrated by surface plasmon
et al., 1998). CD40/CD40L interaction plays a major roleresonance. Coimmunoprecipitation of Mtb HSP70 with
in regulating both humoral and cellular immune re-
CD40 indicates a physical association between these
sponses. Ligation of CD40 activates antigen-presenting
molecules. The results suggest that CD40 is critical in cells by increasing expression of the accessory mole-
microbial HSP70 binding and stimulation of RANTES cules CD80, CD86, and CD54 (Caux et al., 1994; Sallusto
production. and Lanzavecchia, 1994). The CD40/CD40L interaction
also leads to production of inflammatory cytokines, such
Introduction as TNF, IL-1, IL-6, and IL-12 in macrophages and DC
(Kiener et al., 1995; Cella et al., 1996). Stimulation of
Heat shock protein 70 (HSP70) is a member of a family cytokines and chemokines may promote the innate
of molecular chaperones that play an important part in mechanism to instruct the adaptive immune response
protein synthesis, folding, and translocation (Lindquist to generate a diverse repertoire of antigen-specific re-
and Craig, 1988; Pilon and Schekman, 1999). The HSP ceptors distributed on clonally expanded T and B cells
family is among the most highly conserved proteins, (Medzhitov and Janeway, 1997; Hoffmann et al., 1999).
which carry out many of their regulatory activities via Indeed, recent studies demonstrated a central role for
protein-protein interactions (Rothman, 1989; Gething ligation of CD40 on macrophages and DC in the induc-
and Sambrook, 1992). Mycobacterium tuberculosis- tion of MHC class I-restricted antigen-specific CD8
derived HSP70 (Mtb HSP70) is well characterized and T cell responses and protective immunity (Ridge et al.,
functions as an adjuvant in stimulating the host immune 1998; Bennett et al., 1998; Schoenberger et al., 1998).
Here we report that CD40 can mediate Mtb HSP70
stimulation of the human monocyte-derived cell line6 Correspondence: thomas.lehner@kcl.ac.uk
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(THP1), activated myelo-monocytic cell line (KG1), rule out the possibility that any contamination with LPS
played a role in the induction of CC-chemokines by MtbCD40-transfected HEK 293 cell line, blood monocytes,
and PBMC to produce the CC-chemokines RANTES, HSP70 and indicate that Mtb HSP70 and LPS activate
monocytes by different mechanisms.MIP-1, and MIP-1. The CD40-mediated stimulation of
production of RANTES was also found with E. coli Phenotypic analysis revealed that resting cultures of
monocytic THP1 cells expressed CD40 (99.3% 3.1%),HSP70 but not human HSP70. Furthermore, we demon-
strated an association between Mtb HSP70 and CD40 CD14 (93.9%  4.8%), and CD11b (76.4%  3.7%), but
little CD91 (1.3%  3.2%) or CD40L (1.7%  2.7%).by coimmunoprecipitation and by a binding assay using
surface plasmon resonance. These results suggest that Stimulation of CD40 with CD40L on monocytes leads to
the production of CC-chemokines (Kornbluth et al.,CD40 acts as a receptor for microbial HSP70 stimulation
of CC-chemokines. 1998; McDyer et al., 1999). We have also found that
culturing THP1 cells with soluble CD40L trimer (CD40LT),
a biologically functional oligomer of CD40L, elicited aResults
dose-dependent increase in production of RANTES
(data not shown). In order to determine the specificityMtb HSP70 Stimulation of CC-Chemokines
of CD40 interaction with Mtb HSP70, we carried outin the Monocyte Cell Line (THP1)
inhibition assays with antibodies to CD40. Two anti-Is Mediated by CD40
CD40 mAbs (MAB89 and LOB/89) were identified whichWe first studied the induction of CC-chemokines in the
did not stimulate THP1 cells to produce CC-chemokinesmonocytic-derived cell line (THP1). Incubation of THP1
(data not shown). The clone MAB89 (but not LOB) mAbcells with Mtb HSP70-stimulated secretion of RANTES,
inhibited RANTES production in THP1 cells in a dose-MIP-1, and MIP-1 in a dose-dependent manner. The
dependent manner (Figure 1D). Similar results were alsoincreased secretion of CC-chemokines was detected as
observed with MIP-1 (data not shown). The mAb toearly as 4 hr after Mtb HSP70 stimulation and this in-
CD14 (MY4) failed to affect the concentration of RANTEScreased steadily by days 2 and 3 (data not shown). Maxi-
elicited by Mtb HSP70 (Figure 1E). However, LPS-stimu-mal concentration of the three CC-chemokines was ob-
lated production of CC-chemokines was inhibited in aserved after 3 days of culture with 10–20 g/ml of Mtb
dose-dependent manner with anti-CD14 mAb but notHSP70 (Figure 1A). There was no further increase of the
with anti-CD40 (Figure 1E), suggesting that CD40, butthree CC-chemokines at higher doses of Mtb HSP70
not CD14, mediated Mtb HSP70 stimulation of CC-che-(50 g/ml), suggesting that saturation of Mtb HSP70
mokines. The isotype control antibody had no effect onstimulation of monocytes may have taken place as
Mtb HSP70 or LPS-induced CC-chemokine productionshown in the binding assay (Figure 4F). Mtb HSP70 elic-
(Figures 1D and 1E).ited greater than 100-fold increase of RANTES (4728 
252.5 pg/ml) as compared with the unstimulated level
(45 5.2 pg/ml), and this applied also to MIP-1 (2940 Induction of CC-Chemokines in the CD34
Myelo-Monocytic Cell Line Is Dependent123 compared with 22.2  10 pg/ml), and MIP-1
(12,743  130.4 compared with 131.7  15.5 pg/ml). In on Induction of CD40
The CD34 myelo-monocytic cell line (KG1) differenti-order to rule out nonspecific stimulation, THP1 cells
were treated with human serum albumin, and the con- ates into cells with DC features upon stimulation with
PMA and cytokines. During this process, a number ofcentration of the three CC-chemokines remained un-
changed (Figure 1A). DC markers are upregulated, including CD40 (Louis et
al., 1999). Analysis of the surface molecules expressedHSP70 stimulation of monocytes is dependent on the
intracellular calcium flux, which is different from cal- by KG1 cells showed that unstimulated KG1 cells ex-
pressed little CD83, a marker of mature or fully differenti-cium-flux-independent LPS stimulation (McLeish et al.,
1989; Asea et al., 2000). In order to differentiate between ated DC (Zhou and Tedder, 1995) or CD40, and virtually
no CD80, CD86, CD14, or CD40L. Stimulation of KG1Mtb HSP70 and LPS and to elaborate the mechanism
of Mtb HSP70 stimulation of CC-chemokines, we used cells with 10 g/ml of Mtb HSP70 for 3 days upregulated
CD83 (from 2.7%  0.5% to 6.1%  1.5%) and CD40an intracellular calcium chelator BAPTA-AM. This dem-
onstrated that Mtb HSP70 stimulation of THP1 cells pro- (from 3.2%  1.8% to 7.6%  2.6%), but not CD80,
CD86, CD14, or CD40L. Stimulation with PMA, GM-CSF,ducing RANTES was inhibited in a dose-dependent
manner (in a range of 1–100 M) by the intracellular and IL-4 also induced a proportion of KG1 cells to ex-
press CD83 (11.2%  1.7%) and CD40 (7.3%  1.9%).calcium chelator BAPTA-AM (Figure 1B). In contrast,
stimulation of THP1 cells by LPS was not affected by Furthermore, adding Mtb HSP70 to PMA and the cyto-
kines, enhanced the expression of both CD83 (14.6%the treatment with 1–100 M of BAPTA-AM. Thus, Mtb
HSP70, unlike LPS is calcium dependent and the stimu- 0.9%) and CD40 (11.3%  2.3%) without any marked
effect being observed on the other costimulatory mole-lation of RANTES production by the Mtb HSP70 material
is not due to any LPS contaminant. cules (CD80, 1.7%  0.8%; CD86, 3.3%  2.5%), CD14
(0.5%  0.2%), or CD40L (0.1%  0.1%). The resultsWe then treated Mtb HSP70 materials with “Kuttsu
Clean” which removes greater than 99% of LPS (data suggest that the KG1 cells are activated to express CD40
(Figure 2A) and that the increased CD40 stimulated bynot shown) or added polymyxin B (50 g/ml) to the
cultures and found that this had no effect on Mtb HSP70- Mtb HSP70 plus PMA and cytokines reached the 5%
significant level (t  7.363, p  0.01), as compared withinduced RANTES production at concentrations of 5–50
g/ml (Figure 1C). In contrast, polymyxin B suppressed the untreated KG1 cells.
Production of CC-chemokines was then examined inmore than 90% RANTES production induced by a range
of concentrations of LPS (10–1000 ng/ml). These results resting and activated KG1 cells. Resting KG1 cells pro-
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Figure 1. Stimulation of CC-Chemokine Production by Mtb HSP70, as Compared with LPS
(A) Stimulation of CC-chemokine production by Mtb HSP70. THP1 cells (2  105 per ml) were stimulated with 0–50 g/ml Mtb HSP70 () or
HSA (O) for 3 days, and the supernatants were collected for assays of RANTES, MIP-1, and MIP-1. The results of three experiments were
presented as means  SD.
Effects of intracellular calcium chelator BAPTA-AM (B) and polymyxin B (PmB) (C) on Mtb HSP70 stimulation of RANTES production. THP1
cells were stimulated with 20 g/ml of Mtb HSP70 or 200 ng/ml of LPS in the presence of three concentrations of BAPTA-AM. For inhibition,
50 g/ml of polymyxin B was added to Mtb HSP70 or LPS-stimulated THP1 cells. After 3 day culture, RANTES was assayed in the culture
supernatants.
Suppression of CC-chemokine production in THP1 cells stimulated by Mtb HSP70 (D) or LPS (E). (D) THP1 cells were stimulated with 10 g/
ml of Mtb HSP70 in the presence of 1–20 g/ml of antibodies to CD40 (MAB89, ), CD14 (), and control IgG (O). (E) THP1 cells stimulated
with LPS (200 ng/ml) were treated with increasing concentrations of mAb to CD14 (), CD40 (O), or control IgG (). After 3 days, the
supernatants were used to assay RANTES and MIP-1. The results from three independent experiments are presented and expressed as
mean % suppression  SD.
duced very low concentrations of RANTES (11.2 6 pg/ GM-CSF, and IL-4 stimulation. In contrast, no produc-
tion of RANTES was observed in the CD40	 KG1 cellml) or MIP-1 (10.8  5.5 pg/ml) and addition of Mtb
HSP70 up to 50 g/ml failed to elicit any increase in population stimulated with Mtb HSP70 (0.5–50 g/ml)
alone or in the presence of PMA plus GM-CSF and IL-4RANTES or MIP-1 (Figure 2B). Similarly, PMA, GM-CSF,
and IL-4 were also unable to induce CC-chemokine pro- (Figure 2C). The specificity of CD40 in mediating Mtb
HSP70-stimulated CC-chemokine production by KG1-duction (Figure 2B). However, Mtb HSP70 elicited a
dose-dependent increase in RANTES and MIP-1 pro- derived DC was further examined by inhibition assays.
Anti-CD40-specific antibodies inhibited in a dose-duction by KG1 cells, in the presence of PMA, GM-CSF,
and IL-4 that reached concentrations 
100 times those dependent manner Mtb HSP70-induced production of
RANTES (Figure 2D). Thus, Mtb HSP70 stimulates theof the activated cells without stimulation with Mtb
HSP70 (Figure 2B). LPS failed to elicit an increase in production of CC-chemokines only from the CD40 cell
subset of activated KG1 cells, and the specificity ofRANTES or MIP-1 in doses up to 1000 ng/ml in both
resting and PMA-, GM-CSF-, and IL-4-activated KG1 CD40 was demonstrated by inhibition with antibodies
to CD40.cells (Figure 2B).
To confirm that the CD40cell population was respon-
sible for producing the Mtb HSP70-stimulated CC- Induction of CC-Chemokines by Mtb HSP70-
Stimulating PBMC-Derived Monocyteschemokines, activated KG1 cells were separated by cell
sorting into greater than 95% CD40 cells and greater or CD14 Monocyte-Derived DC
To establish that CD40 is involved in CC-chemokinethan 99% CD40	 cells. RANTES was produced in a
dose-dependent manner only by the CD40 cells when induction by stimulation with Mtb HSP70 not only in
human cell lines but also in cells isolated from the circu-stimulated with Mtb HSP70, independently of PMA,
Immunity
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Figure 2. Production of CC-Chemokines by CD40 and CD40	 KG1 Cells, Stimulated with HSP70
(A) Expression of CD40 on KG1 cells following activation. KG1 cells were treated with Mtb HSP70 (10 g/ml), PMA (10 ng/ml), GM-CSF (400
U/ml), and IL-4 (20 U/ml) or a combination of Mtb HSP70, PMA, and the cytokines. Three days after stimulation, 5  105 cell pellets were
incubated with 1 g PE-conjugated antibody to CD40. PE-conjugated IgG isotype served as a control. The result presented is representative
of four experiments.
(B) Induction of CC-chemokines in KG1 cells. KG1 cells (5  105 cells per ml) were stimulated with Mtb HSP70 in the absence (O) or presence
() of PMA (10 ng/ml) with GM-CSF (400 U/ml) and IL-4 (20 U/ml), or stimulated with LPS with () or without () PMA and cytokines. After
72 hr the culture supernatants were removed for the assay of RANTES and MIP-1.
(C) Production of RANTES by CD40 and CD40	 KG 1 cells. CD40 () and CD40	 (O) KG1 cells were purified from activated KG1 by cell
sorting and stimulated with Mtb HSP70 (0–50 g/ml) in the presence or absence of PMA (10 ng/ml) with GM-CSF (400 U/ml) and IL-4 (20
U/ml). After 3 days, the supernatants were used to assay RANTES.
(D) Inhibition of RANTES production by anti-CD40 antibodies. The inhibition was carried out by adding increasing concentrations of anti-CD40
antibodies to Mtb HSP70- (20 g/ml) stimulated KG1 cells in the presence of PMA with GM-CSF and IL-4.
lation, we studied human PBMC-derived monocytes or HEK 293 cells with the cDNA encoding human CD40. Three
days following transfection over 90% cells expressed cellCD14 monocyte-derived DC. Human blood monocytes
(
98% purity) were isolated from PBMC by a cell sorter surface CD40 molecules (Figure 4A). Mtb HSP70 stimu-
lated a dose-dependent increase in the concentration ofusing mAb to CD14. DC were prepared by culturing
CD14 blood monocytes for 7–9 days in the presence RANTES in wild-type CD40-transfected, but not the con-
trol Lac-Z-transfected HEK 293 cells (Figure 4B), whichof GM-CSF and IL-4 (Sallusto and Lanzavecchia, 1994).
A dose-dependent increase in RANTES was found when expressed no CD40 (Figure 4A). There was greater than
20-fold increase in the concentration of RANTES whenPBMC-derived monocytes or immature DC were stimu-
lated with Mtb HSP70 (Figures 3A and 3B). The produc- stimulated with Mtb HSP70, though the level was higher
when stimulated with the CD40L trimer (Figure 4B). Sur-tion of RANTES by primary monocytes or CD14 mono-
cyte-derived DC was significantly inhibited (p  0.05) prisingly, only RANTES was induced with Mtb HSP70
or CD40LT-stimulated CD40 transfected-HEK 293 cells,with antibodies to CD40 (Figures 3C and 3D). The results
with human monocytes or DC are consistent with those and we failed to detect any MIP-1 or MIP-1. This
suggests a different intracellular mechanism for the pro-derived from the monocytic cell lines, suggesting that
Mtb HSP70-induced CC-chemokines is mediated by duction of the three CC-chemokines in the HEK 293
cells as compared with the monocytic THP1 cells or theCD40 receptors.
KG1 cells.
To establish a requirement for CD40 signaling in MtbInduction of RANTES Is Dependent on a Signaling-
Competent CD40 Receptor HSP70-induced release of RANTES, we made use of a
CD40 molecule lacking a cytoplasmic tail (CD40cyt.)To demonstrate the requirement for CD40 in Mtb HSP70-
stimulated CC-chemokine production, we transfected This truncated form of CD40 has been previously shown
CD40 Mediates HSP70 Stimulation of CC-Chemokines
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Figure 3. Induction of CC-Chemokines by
Human Monocytes and CD14 Monocyte-
Derived DC Stimulated with Mtb HSP70
Induction of CC-chemokines by human
monocytes and CD14 monocytes derived
DC stimulated with Mtb HSP70. Aliquots of
(A) 5  105/ml human monocytes and (B)
monocyte-derived DC were stimulated for 3
days with 5, 10, and 20 g/ml of Mtb HSP70.
In the inhibition assay (C and D), mAb to CD40
(10 g/ml) and the control antibody isotype
were added to Mtb HSP70- (10 g/ml) stimu-
lated monocytes and DC. Three days after
culture, the supernatants were removed to
assay RANTES.
to lack signaling activity required for costimulation (Lee concentrations greater than 12.5 g/ml of Mtb HSP70.
However, no binding was observed with FITC-BSA (Fig-et al., 1999). HEK 293 cells were transfected with cDNA
encoding CD40cyt. Flow cytometric analysis shows ure 4C). Binding of FITC-Mtb HSP70 was inhibited by
adding 40-fold excess of unlabeled Mtb HSP70, asthat the majority of cells transfected with CD40cyt ex-
press cell surface CD40, as seen with the wild-type CD40 shown by the reduction of fluorescence intensity (Figure
4C). Mtb HSP70 binding was also inhibited by a 40-foldconstruct (Figure 4A). However, in contrast with HEK
293 cells expressing the wild-type CD40 construct, nei- excess of E.coli HSP70, but not that of human HSP70,
suggesting that human HSP70 binding used distinct re-ther Mtb HSP70 nor the CD40LT stimulated release of
RANTES in HEK 293 cells expressing CD40cyt (Figure ceptors from Mtb HSP70 binding and was independent
of CD40 (Figure 4C). In contrast, the FITC-Mtb HSP704B). These results confirm both the specificity of CD40
and the need for CD40 signaling in Mtb HSP70-induced binding was not affected by addition of unlabeled human
serum albumin.CC-chemokine release.
To determine whether Mtb HSP70 binds to the cell
surface CD40, we used surface plasmon resonance. MtbBinding of Mtb HSP70 to CD40-Transfected
HEK 293 Cells HSP70 was immobilized on the surface of the sen-
sorchip and binding of fluid phase CD40-transfected orOur results demonstrate a requirement for CD40 in Mtb
HSP70-induced CC-chemokine release. Saturation bind- Lac-Z- (control) transfected cells in DMEM supple-
mented with 10% FCS was measured (Figure 5A). CD40ing of HSP70 to CD40 was then determined using FITC-
labeled Mtb HSP70. There was a dose-dependent in- transfected HEK 293 cells bound to immobilized HSP70
and saturation of binding (approximately 275 resonancecrease in Mtb HSP70 binding to CD40-transfected cells,
as compared with the control Lac-Z-transfected HEK units) was found at a concentration of 1.5  107 cells/
ml. In contrast, binding of control Lac-Z-transfected293 cells (Figure 4C). Saturation of the CD40, but not
CD40	 cells, was reached with 25 g/ml of Mtb HSP70. cells was much lower (75 resonance units) at the same
concentration. To confirm the specificity of binding, anti-Although there was no significant binding to Lac-Z-
transfected cells at low concentration of Mtb HSP70 body inhibition experiments were performed. Results of
a representative experiment are shown in Figure 5B.(1.5–12.5 g/ml), nonspecific binding was observed at
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Figure 4. The Cell Surface Expression and Specificity of CD40 Interaction with HSP70 in CD40-Transfected HEK 293 Cells and Saturation
Binding of Labeled Mtb HSP70
(A) Cell surface expression of CD40 in HEK 293 cells transfected with wild-type CD40, CD40cyt, or Lac-Z. An aliquot of 5  105 single-cell
suspension of CD40-transfected or Lac-Z-transfected HEK 293 was incubated with 1 g PE-conjugated antibody to CD40. PE-conjugated
IgG isotype served as a control.
(B) Stimulation of RANTES production in CD40-transfected HEK 293 cells by Mtb HSP70 or CD40LT. 24 hr after transfection with the cDNA
encoding wild-type CD40, CD40cyt, or the control Lac-Z, increasing concentrations of Mtb HSP70 or CD40LT were added to the cell cultures.
The supernatants were collected from day 1 to day 6 and RANTES was assayed. The optimum production of RANTES was seen on day 3
and this data is presented. The experiments were repeated four times.
(C) Saturation binding of FITC-labeled Mtb HSP70 and the inhibition of FITC-Mtb HSP70 binding by unlabeled Mtb HSP70, HSA, or E. coli
HSP70. A cell suspension of CD40 or Lac-Z-transfected HEK 293 cells was incubated with FITC-Mtb HSP70 at 4C at doses of 0–50 g/ml.
For inhibition, CD40-transfected HEK 293 cells were preincubated for 30 min with 40-fold excess of unlabeled Mtb HSP70, E. coli HSP70,
human HSP70, or HSA (indicated by arrows), followed by incubation with 25 g/ml of FITC-Mtb HSP70 for a further 30 min on ice. The cells
were also incubated with 25 g/ml of FITC-BSA as a control. After washing, the cells were analyzed by flow cytometry. The data are
representative of four independent experiments.
Binding of CD40-transfected cells was inhibited in a performed in the absence of recombinant Mtb HSP70
(Figure 6A). No specific bands were seen when blotteddose-dependent manner by addition of anti-CD40 mAb,
with control antiserum (data not shown). No specificwhereas the control anti-CD14 mAb had no effect.
Mtb HSP70 bands were coprecipitated with antibodies
to either CD14 or control IgG isotype antibody (Figure
Association of Mtb HSP70 with CD40 6A). To show that the CD40 association was specific for
To ascertain whether Mtb HSP70 associates with the Mtb HSP70, similar immunoprecipitations were per-
CD40 molecule, detergent extracts from CD40-express- formed following incubation with human HSP70 (Figure
ing THP1 cells were incubated with recombinant Mtb 6B). No bands were coimmunoprecipitated with CD40.
HSP70. CD40-associated proteins were then immuno- To confirm that Mtb HSP70 interacts specifically with cell
precipitated with the mAb to CD40, separated by SDS- surface-expressed CD40, further immunoprecipitations
PAGE, transferred to Immobilon-P membrane, and probed were performed with THP1 cells that were surface-labeled
with antisera specific for Mtb HSP70 (Figure 6A). Immu- by biotinylation. Intact, labeled cells were incubated with
noblot analysis with the Mtb HSP70-specific antibodies Mtb HSP70 at 0 and 50 g/ml on ice. Unbound HSP70
showed a 70 kDa band, which corresponds to Mtb HSP70, was removed by washing, and cells were incubated with
coimmunoprecipitated with the CD40 molecule. This in- antibody to Mtb HSP70, CD40, or isotype-matched
teraction between CD40 with Mtb HSP70 was specific, control antibody (on ice) prior to washing and lysis. Im-
mune complexes, recovered by incubation with proteinas no association was seen in immunoprecipitations
CD40 Mediates HSP70 Stimulation of CC-Chemokines
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Figure 5. Binding of Mtb HSP70 to CD40-Transfected HEK 293 Cells by Surface Plasmon Resonance
Binding of Mtb HSP70 to CD40-transfected HEK 293 cells. Binding of fluid-phase HEK 293 cells transfected with CD40 or Lac-Z (control) to
immobilized Mtb HSP70 was determined by surface plasmon resonance.
(A) Comparison of CD40 and Lac-Z-transfected cells. The superimposed sensorgrams show binding at a concentration of 1.5  107 cells/ml.
Flow rate was 1 l/min and injection volume was 20 l. The period of injection (association phase) is indicated by arrow (↓). In this experiment,
binding of CD40-transfected cells reaches saturation.
(B) Inhibition of binding in the presence of anti-CD40 mAb (MAB89). CD40-transfected cells were injected in the presence of anti-CD40 or
control anti-CD14 mAb at 130 nM and 65 nM concentrations. Results of a representative experiment are shown as binding (%) relative to
binding in the absence of mAb. Magnitude of binding was measured as the difference (resonance units) over the period of injection as in (A).
G-Sepharose, were analyzed by SDS-PAGE. Following HSP70359–610 or E. coli HSP70 was further studied by using
CD40-transfected HEK 293 cells. Mtb HSP70359–610 orelectrophoretic transfer onto a nitrocellulose membrane,
biotinylated polypeptides were visualized by chemilumi- E. coli HSP70 stimulated a dose-dependent increase in
production of RANTES in CD40-transfected, but not innescence using streptavidin-conjugated HRP. Antibody
to CD40 precipitated a polypeptide of approximately 42 Lac-Z-transfected HEK 293 cells (Figures 7D and 7E).
In contrast, incubation with increasing doses of humankDa, and a band with the same electrophoretic mobility
was also coimmunoprecipitated by antibody to Mtb HSP70 (up to 50g/ml) failed to elicit significant produc-
tion of RANTES in CD40-transfected and the controlHSP70 (Figure 6C, left panel). The identity of this poly-
peptide band was confirmed to be CD40 by immunoblot Lac-Z-transfected HEK 293 cells (Figure 7F). The results
suggest that CD40 mediates E. coli HSP70, but not hu-analysis with the antibody to CD40 of immunoprecipi-
tates prepared in an identical manner using unlabeled man HSP70, stimulation of CC-chemokines.
cells (Figure 6C, right panel). An isotype matched control
antibody failed to precipitate CD40. Discussion
The primary function of CC chemokines is to attractStimulation of CC-Chemokines by Mtb HSP70
N- and C-Terminal Fragments or E. coli antigen-processing and -presenting macrophages and
DC, as well as effector T and B cells. We report hereHSP70 and Human HSP70
HSP70 consists of two major functionally distinct do- that Mtb HSP70 stimulates a human monocyte-derived
cell line (THP1), CD34 myelo-monocytic cell line (KG1),mains: N-terminal ATPase portion (aa 1–358) and a
C-terminal peptide binding domain (aa 359–540), with which on activation differentiates into dendritic-like
cells, blood monocytes, and CD14-derived DC to pro-an adjacent portion (aa 541–625) of unknown function.
Stimulation of monocytic THP1 cells with the HSP70 duce CC-chemokines. A significant finding of this study
is that induction of CC-chemokines by Mtb HSP70 isC-terminal fragment (aa 359–610), but not the N-terminal
fragment (aa 1–358), elicited a dose-dependent increase dependent on the cell-surface expression of CD40. The
CD40 specificity was established (a) by inhibitingin production of RANTES (Figure 7A).
E. coli HSP70 or human HSP70 also stimulated THP1 RANTES production with anti-CD40 antibodies or (b) by
transfecting mutagenized CD40 molecule on HEK 293cells to produce RANTES in a dose-dependent manner
(Figure 7A), which was similar to that observed with Mtb cells, (c) by a physical association between Mtb HSP70
and CD40 demonstrated by binding assay using surfaceHSP70. However, human HSP70, unlike Mtb HSP70, was
inhibited by antibodies to CD14 but not antibodies to plasmon resonance, and (d) by immunoprecipitation
with CD40 specific antiserum. CD40-mediated activa-CD40 (Figure 7B), which is consistent with the report
that CD14 is a receptor for human HSP70 (Asea et al., tion of DC and monocytes by Mtb HSP70 may be an
important mechanism in the innate function of Mtb2000). In contrast, antibodies to CD40, but not to CD14,
significantly inhibited E. coli HSP70 stimulation of RANTES HSP70 stimulation of CC-chemokines.
Themonocytic THP1cell line used in thisstudy expresses(Figure 7C). The CD40-dependent stimulation by Mtb
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Figure 6. Immunoblot Analysis of Mtb or Hu-
man HSP70 Association with CD40 Using An-
tibodies to CD40 or CD14
Immunoprecipitation of Mtb HSP70 with anti-
bodies to CD40. THP1 cell lysates that had
been incubated with recombinant Mtb HSP70
(A) or human HSP70 (B) were precipitated
with rabbit antibodies to CD40, rabbit control
IgG, mAb to CD14 (A), or isotype control mAb
(primary antibodies). The immunoprecipi-
tated products were then analyzed by immu-
noblot with antibodies (secondary antibody) to
Mtb HSP70 (A) or to human HSP70 (B). (C) Im-
munoprecipitation of cell surface CD40 by Mtb
HSP70 was carried out on THP1 cells. Biotinyl-
ated THP1 cells were treated with 0 and 50g/
ml of Mtb HSP70, followed by antibody to Mtb
HSP70 or CD40. THP1 cells incubated with
50 g/ml of Mtb HSP70 were also treated
with isotype-matched control antibody. After
detergent lysis, immune complexes were re-
covered by incubation with protein G-Sepha-
rose, separated on SDS-PAGE, and visual-
ized directly with streptavidin-HRP (left
panel). Immune complexes prepared in an
identical manner to the unlabeled cells were
probed with antibody to CD40 (right panel).
CD40 (99%), but stimulation with Mtb HSP70 upregulates HSP70-induced CC-chemokine production. The specific-
ity of CD40-mediated activation of KG1 cells by Mtbthe cell surface expression of CD40 and generates high
levels of RANTES, MIP-1, and MIP-1. We failed to detect HSP70 was demonstrated by inhibition of CC-chemokine
production by antibodies to CD40, which is consistentCD40L expression on resting or Mtb HSP70-activated
THP1 cells, and this eliminated the possibility that CD40 with the report that ligation of CD40 on DC induces
CC-chemokines (McDyer et al., 1999).and CD40L interaction between monocytes was responsi-
ble for the generation of CC-chemokines, as has been Receptor-mediated HSP binding has been shown on
antigen-presenting cells (Castellino et al., 2000; Binderpreviously shown (Kornbluth et al., 1998). Stimulation of
KG1 cells with Mtb HSP70 upregulates the CD83 matura- et al., 2000a; Basu et al., 2001; Arnold-Schild et al., 1999).
CD14 and Toll-like receptor 4 have been described astion marker of DC, as well as CD40 molecules. These
results were similar to those induced by PMA with GM-CSF receptors for human HSP65 and HSP70 in stimulation
of antigen-presenting cells (Asea et al., 2000; Kol et al.,and IL-4 which drive KG1 cells to differentiate to dendritic-
like cells (Louis et al., 1999), suggesting that Mtb HSP70 2000; Ohashi et al., 2000). A recent study indicates that
the2 macroglobulin receptor (CD91) is a surface recep-may play a role in DC maturation, as has been demon-
strated with mammalian HSP70 (Basu et al., 2000). It is tor shared by the human HSP70, HSP90, and gp96 in
priming CD8 cytotoxic T lymphocytes (Binder et al.,noteworthy that Mtb HSP70 elicited CC-chemokine pro-
duction only in KG1 cells activated with PMA, GM-CSF, 2000b; Basu et al., 2001). However, so far no receptor
has been described for HSP derived from prokaryoticand IL-4 in which CD40 expression was significantly
upregulated. Upregulation of CD40 to a threshold may be cells. Although HSPs are conserved across species, us-
age of receptors differs; human but not bacterial HSP60essential for stimulation of RANTES production. Indeed,
unlike the CD40	 population, cell sorter separated CD40 utilize CD14 (Ohashi et al., 2000). We have found that
CD40 mediates Mtb, but not human HSP70, to generateKG1 cells (greater than 90%) were capable of producing
CC-chemokines following Mtb HSP70 stimulation in the CC-chemokines.
In the receptor-mediated binding assay, FITC-labeledabsence of PMA and the cytokines. This is consistent with
the findings that the CD40 receptors are involved in Mtb Mtb HSP70 binds to CD40-transfected HEK 293 cells in
CD40 Mediates HSP70 Stimulation of CC-Chemokines
979
Figure 7. A Comparison of Stimulation of THP1 Cells with Native Mtb HSP70 or Its Two Fragments, E. Coli HSP70 and Human HSP70
Stimulation of THP1 cells with native Mtb HSP70 or its two fragments, E. coli HSP70 and human HSP70 (A) and effects of antibodies to CD40
or CD14 on the HSP70 stimulation (B and C). Aliquots of 2  105 THP1 cells were treated with different doses of native Mtb HSP70 or its two
fragments, E. coli HSP70 and human HSP70. In the inhibition assays 20 g/ml of antibodies to CD40, CD14, or control IgG isotype were
included. The supernatant was taken 3 days after stimulation to assay RANTES. For induction of RANTES in CD40-transfected HEK 293 cells,
confluent CD40, or Lac-Z-transfected HEK 293 cells were incubated with 1–20 g/ml of the C-terminal Mtb HSP70 (359–610) fragment (D),
E.coli HSP70 (E), or human HSP70 (F) for 4–5 days. The supernatant was then assayed for the production of RANTES. These experiments
were repeated three times and the data presented as mean  SEM.
a dose-dependent manner, as compared with the same calcium flux, unlike the calcium flux-dependent HSP
stimulation (McLeish et al., 1989; Asea et al., 2000).cell lines transfected with the control Lac-Z. The binding
was saturated at 25–50 g/ml of Mtb HSP70 and could Treatment of THP1 cells with an intracellular calcium
chelator (BAPTA-AM) prior to stimulation with Mtbbe competed by excess unlabeled Mtb or E. coli HSP70.
Immunoprecipitation also demonstrated a physical as- HSP70 or LPS inhibited RANTES production with the
former but not with the latter. A number of further controlsociation between CD40 and Mtb HSP70. Using surface
plasmon resonance, we consistently found that CD40 experiments indicated that neither contaminating LPS
nor other bacterial products were involved in Mtbtransfected-, but not Lac-Z transfected-HEK 293 cells,
bind specifically to Mtb HSP70, which can be inhibited HSP70-induced CC-chemokine production. Antibodies
to CD14, but not those to CD40, suppressed CC-chemo-by antibodies to CD40. This technique is most commonly
applied to analysis of fluid phase molecules but has also kines induced by LPS. The LPS inhibitor polymyxin B
inhibited LPS-induced, but not Mtb HSP70-inducedbeen used to determine binding of intact cells (Quinn et
al., 1997; Seo et al., 1997). It is not clear at present if CC-chemokines. Treatment of Mtb HSP70 with “Kuttsu
Clean” which removes 
99% of LPS from the MtbCD40 alone is adequate to function as a receptor or
whether CD40 is a constituent part of a receptor complex, HSP70 preparation did not alter the Mtb HSP70 activity
in the induction of CC-chemokines (data not shown).which serves as a pattern recognition receptor that can
discriminate between human and pathogenic bacterial Furthermore, a preparation of the recombinant Mtb
HSP70 N-terminal ATPase fragment purified by theHSP70. We are mindful of the increasing complexity of
the LPS-CD14 receptor interaction, which requires LPS same procedures as Mtb HSP70 failed to stimulate
CC-chemokine production, indicating that contamina-binding protein and a Toll-like receptor (Wright et al.,
1990; Yang et al., 1999; Qureshi et al., 1999). tion with a bacterial product was unlikely to be involved.
HSP70 is one of the most conserved protein familiesLPS induces a high concentration of CC-chemokines
(Verani et al., 1997), so it was essential to exclude any among various species. There is about 60% homology
between human and Mtb HSP70 and 70% betweencontaminating LPS. LPS stimulation is independent of
Immunity
980
tography on DEAE cellulose. The specificity was demonstrated byE. coli and Mtb HSP70 (Bardwell and Craig, 1984). We
Western blotting and dose-dependent adsorption with Mtb HSP70-have reported here that Mtb HSP70 and E. coli HSP70
coated Sepharose-4B beads by ELISA.stimulated THP1 cells to produce RANTES and that both
were mediated by CD40, unlike, human HSP70 which is
Cell LinesCD14 dependent. We do not have an explanation for this
The monocytic THP1 cell line was obtained from the MRC (NIBSC,differential receptor usage, but a homology plot of con-
Potters Bar, UK). The nonadherent THP1 cell line was cultured inserved amino acids between human and E. coli HSP70
RPMI 1640 medium supplemented with 10% FCS, 100 g/ml of
varies between 20% and 80% (Hunt and Morimoto, 1985). penicillin and streptomycin, and 2 mM glutamine, and the medium
However, the epitope resides within the C-terminal pep- was replaced every 3–4 days. KG1 cells were a generous gift from
tide binding domain (HSP70359–610), which stimulated Dr. K. Lee of the Naval Medical Research Institute, Bethesda, MD..
The cells were maintained in RPMI 1640 medium supplemented withproduction of RANTES and not the N-terminal fragment
10% FCS, 10% minimum essential medium (MEM), 100 g/ml of(aa 1–358).
penicillin and streptomycin, and 2 mM glutamine. The human embry-In summary, this study demonstrated that Mtb HSP70
onic kidney cell line (HEK 293 cells) was acquired from the NIH
stimulates monocytes and DC to produce CC-chemo- (Bethesda, MD) and was maintained in DMEM supplemented with
kines and that this stimulation is mediated by the CD40 10% FCS, 2 mM glutamine, 100g/ml of penicillin and streptomycin,
molecule and is inhibited by anti-CD40 but not anti- and passaged every 3–4 days. All three types of cell lines were
found to be CD40L negative (data not shown).CD14 antibodies. CD40 transfected with the wild-type,
unlike a mutagenized CD40, was essential for stimula-
tion of monocytes by HSP70. Coimmunoprecipitation Transfection of HEK 293 Cells with Wild-Type
of CD40 with HSP70 and binding of HSP70 to CD40 or Mutagenized CD40
Full-length human CD40 cDNA in the pCDM8 plasmid vector (In-expressed on the cell surface suggest that CD40 is a
vitrogen, San Diego, CA) was a kind gift from Dr B. Seed (Sta-receptor or part of a receptor complex for Mtb HSP70.
menkovic et al., 1989). A deletion mutant lacking the cytoplasmic
tail of CD40 (CD40cyt) (Lee et al., 1999) was subcloned from theExperimental Procedures
pBABEpuro CD40cyt vector into pCDM8. This was performed by
replacing the pCDM8 wild-type CD40 Sph1/Not1 fragment with theReagents
Sph1/Sal1 fragment from the pBABEpuro CD40cyt vector. pCDM8The recombinant Mtb HSP70 was prepared from the E.coli. pop
encoding the E. coli -galactosidase (Lac-Z) was used as a control.strain, which is deficient in bacterial HSP70. The protein was purified
The cells were cultured in 25 cm2 flasks or 24-well plates until 30%–by Q-Sepharose followed by ATP affinity chromatography. The
50% confluence and transfected using LipofectAmine Plus (GIBCOQ-Sepharose chromatography was repeated in order to remove
Life Technologies, Paisley, UK). Transfection was performed ac-endotoxin, which was tested by the Limulus amebocyte lysate assay
cording to the manufacturer’s protocol and CD40 was detected byand showed 1.2 pg of endotoxin per 1 g Mtb HSP70 protein. In
flow cytometry using PE-conjugated CD40 mAb. The assays weresome experiments Mtb HSP70 was further treated with Kuttsu Clean
carried out sequentially at days 2, 3, 4, and 5 after transfection, and(Maruha Corporation, Ibaraki, Japan), which removes greater than 99%
the percentage of CD40 cells was consistently greater than 65%.of LPS. DNA encoding the N-terminal ATPase (aa 1–358) domain of
HSP70 was cloned and expressed in E. coli using the pET 22b vector.
Similarly, DNA encoding the C-terminal peptide binding domain (aa
Induction of CC-Chemokines
359–610) was expressed using pJLA603 vector (Singh et al., 1992).
THP1 cells (2  105 ml), KG1 cells (5  105/ml), or transfected HEK
Cloned inserts were verified by DNA sequence analysis. In both cases,
293 cells (80%–90% confluent) were cultured in 24-well plates and
recombinant polypeptides were prepared by affinity chromatography
incubated with various concentrations of HSP70 (0.5–50 g/ml), or
using Ni2-chelating resin and identity of the polypeptides was con-
CD40LT (0.1–5 g/ml). Human serum albumin was used as a negative
firmed by N-terminal sequence analysis (ten cycles for each). Human
control. To rule out the effect of any remaining contamination with
recombinant HSP70 was a kind gift from Dr. S. Jindal (Cambridge,
LPS in the HSP70 preparation, 50 g/ml of polymyxin B was added
MA). E. coli. HSP70 was obtained from Stressgen (Bioquote, York, UK).
to the cultures of monocytes stimulated with either HSP70 or LPS.
Soluble CD40 ligand trimer (CD40LT, Immunex) was kindly donated by
To activate KG1 cells, PMA (20 ng/ml), GM-CSF (400 U/ml), and IL-4
Dr. F. Villinger (Atlanta, Georgia). Monoclonal antibodies to CD14 (clone
(20 U/ml) were added to the KG1 cell cultures (Louis et al., 1999).
MY4), CD40 (clone MAB89), CD80, and CD86 were purchased from
After 3–5 days, the supernatant was used to assay CC-chemokines.
Immunotech (Oxford, UK). The antibodies to CD14, CD40 (clone LOB),
CD40L, CD83, and control murine monoclonal antibody isotypes were
obtained from Serotec (Oxford, UK). MAb to CD91 was obtained from Cell Sorting
Dako (clone A2MR-2, Cambridgeshire, UK) and mAb to TLR4 CD40 and CD40	 KG1 cells were sorted on a MoFlo flow cytometer
(MTS510), which reacts with mouse and human TLR4, was kindly (Cytomation, Colorado) by using PE-conjugated antibodies to CD40
donated by Dr. Miyake (Saga Medical School, Japan). The human (10 l per 106 cells). Positive and negative CD40 subsets were col-
recombinant GM-CSF was obtained from Leucomax (Sandoz Phar- lected, and the purity was monitored after every sorting and showed
maceuticals, Surrey, UK) and human recombinant IL-4 from R&D consistently 
98%. Collected CD40 and CD40	 population were
System (Abingdon, UK). BAPTA-AM, polymyxin B, LPS, and PMA washed and resuspended in RPMI medium containing 10% FCS
were obtained from Sigma (Dorset, UK). and MEM, 2 mM glutamine, and 100 g/ml of penicillin and strepto-
mycin at a concentration of 2  105 per ml. The cells were placed
Antibodies for Immunoprecipitation and Western Blot onto 96-well plates and incubated overnight. After 24 hr culture,
Two antibodies to CD40 were used in the immunoprecipitation and Mtb HSP70 was added at various concentrations in the presence
Western blot experiments. An affinity-purified rabbit polyclonal anti- or absence of PMA plus GM-CSF and IL-4. Following culture for 3
body to CD40 showed specificity to a peptide mapping at the car- days, the supernatants were collected for the CC-chemokine assay.
boxyl terminus, as demonstrated by Western blot and was obtained
from Santa Cruz Biotechnology (Wiltshire, UK). The immunoprecipi-
tation antibody specific to the surface CD40 was murine monoclonal Inhibition of Production of CC-Chemokines
THP1 cells or KG1 cells were stimulated with either 10 g/ml ofantibody and was obtained from Serotec. The CD14 murine mono-
clonal antibody used for immunoprecipitation and Western blot was HSP70 or 100 ng/ml of LPS in the presence of antibodies to CD14
(1–20 g/ml), CD40 (1–20 g/ml), or the isotype-matched controlpurchased from Santa Cruz. The antibody to Mtb HSP70 was raised
in our laboratory, by immunizing rhesus macaques with recombinant antibody. After 3 days of culture, the supernatants were collected
for CC-chemokine assays.Mtb HSP70. An IgG fraction was prepared by ion exchange chroma-
CD40 Mediates HSP70 Stimulation of CC-Chemokines
981
Induction of CC-Chemokines in Primary Cultures lysate was incubated with 50 g/ml of Mtb HSP70 or human HSP70
at 4C. The mixture was then incubated with rabbit antibodies toof Monocytes, DC, and PMBC
Human blood was taken from healthy laboratory workers and PBMC CD40, rabbit control antibodies, or mouse anti-CD14 mAb or isotype
control mAb for 60 min, followed by 1 hr incubation with proteinwere prepared by Ficoll-Hypaque gradient centrifugation at 1000  g
for 15 min. The cells were washed and resuspended in 10% FCS-RPMI G-Sepharose. The precipitate was washed three times in lysis buffer,
suspended in Laemmli sample buffer, and separated by SDS-PAGE,medium at a concentration of 1  106 per ml. Human PBMC-derived
monocytes were isolated by cell sorting (MoFlo) using PE-conju- followed by electrophoretic transfer to a nitrocellulose membrane
(Immobilon, Millipore UK). The membranes were probed with eithergated antibodies to CD14 as described above. DC were generated
by culturing CD14 monocytes for 7–9 days in the presence of rabbit antibodies to CD40, mAb to CD14, simian antibodies to Mtb
HSP70, or control antibody, and detected by chemiluminescenceGMCSF and IL-4. Purified monocytes (
98%) were resuspended at
5 105/ml, and these as well as the DC were stimulated with increas- (Amersham, Buckinghamshire, UK).
For immunoprecipitation of cell surface CD40, THP1 cells wereing concentrations of Mtb HSP70. For the inhibition studies, 10 g/
ml of anti-CD40 antibodies or controls were added, and after 3 days surface biotinylated and then incubated with Mtb HSP70 at 0 and
50 g/ml for 30 min on ice. After washing, the cells were incubatedthe supernatant were used to assay CC-chemokines.
with antibody to Mtb HSP70, CD40, or isotype-matched control
antibody on ice for further 30 min. After further washing, the cellsELISA for RANTES, MIP-1, and MIP-1
were lysed using 150 mM isotonic tris-HCL buffer (pH 7.3) withThe CC-chemokines were assayed in the culture supernatants gen-
1% CHAPS (lysis buffer) for 30 min at 4C. Insoluble material waserated by stimulation of THP1, KG1, and HEK 293 cells with HSP70.
removed by centrifugation and the supernatant was incubated withThe supernatants collected from THP1 cells were diluted ten times
protein G-Sepharose at 4C for 30 min. Sepharose beads were thenand KG1 or HEK 293 cell culture supernatant five times. Specific
washed three times with lysis buffer and incubated with sampleELISA kits were used for CC-chemokines (R&D System), and the
buffer containing 1% SDS for 3 min at 100C. The complexes wereresults were expressed in pg/ml.
separated by SDS-PAGE, transferred to nitrocellulose membrane,
and visualized by chemiluminescence. Immunoprecipitates pre-Flow Cytometry Analysis
pared in an identical manner from unlabeled cells were analyzed byAliquots of 2  105 either THP1 or KG1 cells were incubated with
Western blot with antibody to CD40.10 l of PE-conjugated antibodies to CD40, CD40L, or CD14 and
PE-conjugated mouse IgG1 isotype for 30 min on ice. After washing
Statistical Analysistwice, the cells were fixed in 1% formaldehyde before analysis by
The differences of the groups were analyzed by the Anova F-test,flow cytometry. For indirect staining, the cells were incubated with
and the significance was analyzed by the paired “t” test.the primary antibodies to CD80, CD83, CD86, or CD40L for 30 min
on ice, followed by FITC-labeled rabbit anti-mouse IgG (Dako, Bucks,
AcknowledgmentsUK) for further 30 min. The cells were analyzed on a Coulter XL-MCL
cytometer, and the data was analyzed on a Software WinMID.
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